Acelyrin (NASDAQ:SLRN) shares lost ~32% after the clinical-stage biotech announced new results from a Phase 2 trial for ...

For the second year in a row, Bausch + Lomb has joined with the Glaucoma Research Foundation to launch the “Faces of Glaucoma ...

Toll-like receptors (TLRs) are vital components of the immune system, acting as sentinels that detect and respond to ...

Recent discoveries in genetic editing technologies are paving the way for treatments aimed at correcting genetic mutations that cause various diseases, including rare conditions like progeria. This ...

Totality of data observed with subcutaneous lonigutamab in Thyroid Eye Disease (TED) patients demonstrate potential for efficacy in line with ...

Some people have labeled glaucoma as the quiet disease, until it steals your vision, and then there are symptoms. In this ...

Malaysia's leading eye care provider, proudly announces a major milestone in the treatment of dry eye disease.

Designation will ease the gene-based breakthrough’s transition from laboratory to clinic with tax breaks and other investment ...

Kim Hartman, a talented artist and Type 1 diabetes patient, has always expressed herself through her vibrant paintings and ...

Your eye doctor will want to know about your ... include management of any underlying conditions, like autoimmune diseases. Treatment is important and can prevent serious complications.

Regeneron has bought Oxular, a UK-based specialist in retinal diseases, in a move that bolsters its already strong position ...

Visakhapatnam: Women are 50% to 60% more susceptible to a range of eye disorders compared to men, according to doctors, many ...